CP 118

Drug Profile

CP 118

Alternative Names: COL 118; CP118

Latest Information Update: 20 Mar 2014

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Collegium Pharmaceutical
  • Class Antihistamines
  • Mechanism of Action Histamine receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Allergic rhinitis

Most Recent Events

  • 20 Mar 2014 Discontinued - Phase-II for Allergic rhinitis in USA (PO)
  • 27 May 2009 Efficacy data from a phase II trial in Allergic rhinitis released by Collegium
  • 07 Mar 2007 Results from a phase II clinical trial in patients with Allergic rhinitis have been added to the adverse events section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top